Cancer cases are globally on the rise, causing an increasing demand for their treatment. As a response, Heraeus Pharmaceutical Ingredients expanses its production capacities for Platinum-based Highly Potent Active Pharmaceutical Ingredients (Pt hAPIs).
The new production line is technically set up and expected to start with commercial production by end 2020, all located at the company’s headquarters in Hanau, Germany. With the multi-million Euro investment, Heraeus reinforces its worldwide market leadership position in this field, underscoring the company’s long tradition in top-quality precious metal technologies. The new expansion will further increase the company's market share.